BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer
Bryan Schneider, MD
Bryan P Schneider; Guanglong Jiang; Tarah J Ballinger; Fei Shen; Christopher Chitambar; Rita Nanda; Carla Falkson; Filipa C Lynce; Christopher Gallagher; Claudine Isaacs; Marcelo Blaya; Elisavet Paplomata; Radhika Walling; Karen Daily; Reshma Mahtani; Michael A Thompson; Robert Graham; Maureen E Cooper; Dean C Pavlick; Lee A Albacker; Jeffrey Gregg; Jeffrey P Solzak; Yu-Hsiang Chen; Casey L Bales; Erica Cantor; Bradley A Hancock; Nawal Kassem; Paul Helft; Bert O'Neil; Anna Maria V Storniolo; Sunil Badve; Kathy D Miller; Milan Radovich